Related Experiment Videos
Radical cystectomy for stage T3b bladder cancer
1Division of Urology, University of Texas Southwestern Medical School, Dallas 75235-9110, USA.
Seminars in Urologic Oncology
|May 1, 1996
Summary
Radical cystectomy offers excellent outcomes for organ-confined bladder cancer. However, for advanced stages with extravesical extension, multimodal therapy including chemotherapy and radiotherapy is crucial for improved survival.
Area of Science:
- Uro-oncology
- Surgical oncology
- Medical oncology
Background:
- Radical cystectomy with pelvic lymphadenectomy is standard for muscle-invasive bladder cancer.
- Excellent outcomes are observed in organ-confined disease (local control >90%, 5-year survival ~80%).
- Radical cystectomy alone is insufficient for patients with extravesical extension, who face high relapse risk.
Purpose of the Study:
- To evaluate the efficacy of multimodal therapy for muscle-invasive bladder cancer with extravesical extension.
- To determine the role of preoperative radiotherapy and systemic chemotherapy in conjunction with radical cystectomy.
- To assess the reliability of clinical staging in patient selection for multimodal treatment.
Main Methods:
- Review of recent data on combined local therapy and systemic chemotherapy.
- Analysis of outcomes in patients with clinical extravesical extension (T3b/T4).
- Evaluation of clinical staging accuracy for patient selection.
Main Results:
- Patients with clinical extravesical extension may benefit from combined therapy.
- Preoperative radiotherapy and multi-agent systemic chemotherapy show promise.
- Clinical staging appears reliable for selecting patients for multimodal approaches.
Conclusions:
- Multimodal therapy is essential for muscle-invasive bladder cancer with extravesical extension.
- Systemic chemotherapy and radiotherapy integration with radical cystectomy improves outcomes.
- Accurate clinical staging enables effective patient selection for neoadjuvant treatment.